Reported about 1 year ago
The article discusses the current bull market, focusing on S&P 500 reaching record highs led by technology stocks, especially in AI. It mentions the importance of looking beyond the bull market and highlights three stocks in biotech and pharma sectors. Novavax has rebounded due to its partnership with Sanofi, Pfizer is focusing on new drugs and oncology, and Ginkgo Bioworks is expanding its cell engineering programs. The article suggests these stocks have the potential to soar in the long run.
Source: YAHOO